JPS6041615A - コロニ−形成刺激因子の製造方法 - Google Patents

コロニ−形成刺激因子の製造方法

Info

Publication number
JPS6041615A
JPS6041615A JP58148588A JP14858883A JPS6041615A JP S6041615 A JPS6041615 A JP S6041615A JP 58148588 A JP58148588 A JP 58148588A JP 14858883 A JP14858883 A JP 14858883A JP S6041615 A JPS6041615 A JP S6041615A
Authority
JP
Japan
Prior art keywords
ultrafiltration membrane
csf
molecular weight
stimulating factor
colony stimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58148588A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6160050B2 (enExample
Inventor
Kazuo Morimoto
森本　和郎
Yoshiaki Kawahata
河畠　芳明
Takehiko Kawano
川野　武彦
Terufumi Fujiwara
藤原　照史
Satoru Funakoshi
船越　哲
Takuji Kawashima
拓司 川島
Morio Kuboyama
久保山　盛雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Morinaga Milk Industry Co Ltd
Mitsubishi Tanabe Pharma Corp
Shingijutsu Kaihatsu Jigyodan
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Morinaga Milk Industry Co Ltd
Research Development Corp of Japan
Shingijutsu Kaihatsu Jigyodan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Morinaga Milk Industry Co Ltd, Research Development Corp of Japan, Shingijutsu Kaihatsu Jigyodan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP58148588A priority Critical patent/JPS6041615A/ja
Publication of JPS6041615A publication Critical patent/JPS6041615A/ja
Publication of JPS6160050B2 publication Critical patent/JPS6160050B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP58148588A 1983-08-12 1983-08-12 コロニ−形成刺激因子の製造方法 Granted JPS6041615A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58148588A JPS6041615A (ja) 1983-08-12 1983-08-12 コロニ−形成刺激因子の製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58148588A JPS6041615A (ja) 1983-08-12 1983-08-12 コロニ−形成刺激因子の製造方法

Publications (2)

Publication Number Publication Date
JPS6041615A true JPS6041615A (ja) 1985-03-05
JPS6160050B2 JPS6160050B2 (enExample) 1986-12-19

Family

ID=15456102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58148588A Granted JPS6041615A (ja) 1983-08-12 1983-08-12 コロニ−形成刺激因子の製造方法

Country Status (1)

Country Link
JP (1) JPS6041615A (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01175995A (ja) * 1987-12-29 1989-07-12 Sumitomo Pharmaceut Co Ltd 生理活性物質の農縮・脱塩方法
US5470569A (en) * 1985-02-05 1995-11-28 Cetus Oncology Corporation Recombinant colony stimulating factor-1
JPH08217449A (ja) * 1995-02-21 1996-08-27 Agency Of Ind Science & Technol 石油系燃焼灰からそれに含まれる金属を抽出する方法
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US6103224A (en) * 1985-02-05 2000-08-15 Chiron Corporation N∇2 CSF-1 (short form) and carboxy truncated fragments thereof
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470569A (en) * 1985-02-05 1995-11-28 Cetus Oncology Corporation Recombinant colony stimulating factor-1
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US5643563A (en) * 1985-02-05 1997-07-01 Chiron Corporation N-∇3 deletion mutants of the short form of CSF-1
US5672343A (en) * 1985-02-05 1997-09-30 Chiron Corporation N- 3 deletion mutants of the long form of CSF-1
US5681719A (en) * 1985-02-05 1997-10-28 Chiron Corporation DNA encoding N- and C- terminally truncated colony stimulating factor-1 variants
US6103224A (en) * 1985-02-05 2000-08-15 Chiron Corporation N∇2 CSF-1 (short form) and carboxy truncated fragments thereof
US6117422A (en) * 1985-02-05 2000-09-12 Chiron Corporation N∇2-CSF-1(long form) and carboxy truncated fragments thereof
US6146851A (en) * 1985-02-05 2000-11-14 Chiron Corporation DNA encoding NV2 (long form) and carboxy truncated fragments thereof
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US6204020B1 (en) 1985-02-05 2001-03-20 Chiron Corporation DNA encoding N∇2 CSF-1 (short form) and carboxy truncated fragment thereof
JPH01175995A (ja) * 1987-12-29 1989-07-12 Sumitomo Pharmaceut Co Ltd 生理活性物質の農縮・脱塩方法
JPH08217449A (ja) * 1995-02-21 1996-08-27 Agency Of Ind Science & Technol 石油系燃焼灰からそれに含まれる金属を抽出する方法

Also Published As

Publication number Publication date
JPS6160050B2 (enExample) 1986-12-19

Similar Documents

Publication Publication Date Title
CA1128881A (en) Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
US4482485A (en) Method of preparation of human urine origin colony-stimulating factor and kallikrein
US6194208B1 (en) Modified milk growth factor
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
CN107163138A (zh) 一种人血浆蛋白α1‑抗胰蛋白酶的分离纯化方法
JPS6041615A (ja) コロニ−形成刺激因子の製造方法
CN106928344A (zh) 用于从含有凝血因子的溶液中减少和/或除去FXI和FXIa的方法
CN101134776A (zh) 制备α1－抗胰蛋白酶的方法
DE68928138T2 (de) Neuer megakaryokytischer koloniestimulierender faktor und verfahren zur herstellung
DE69719382T2 (de) VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1
JPS6159610B2 (enExample)
KR930008097B1 (ko) 콜로니 형성 자극 인자의 정제방법
WO1984002912A1 (fr) Proteine a effet oncostatique, son procede de preparation et mediament oncostatique la contenant
JPWO2005078078A1 (ja) ラクトパーオキシダーゼの製造方法
JPH0244515B2 (enExample)
JPH054929A (ja) 抗ウイルス活性物質の分画精製方法
CN113045634B (zh) 一种补体h因子制备方法
JPS59210027A (ja) Ｃｓｆの製造法
CN105663142A (zh) 一种促进间质细胞ngf分泌的试剂
JPH09309838A (ja) 生体防御機能増強剤
CN109485711B (zh) 一种蚁狮小分子肽及其分离纯化方法和应用
TW201634057A (zh) 具有護骨功效之鱸魚萃取物
CN107141372A (zh) 复合酶提取肝素的方法
JPS608226A (ja) 低分子蛋白質を有効成分とする制ガン剤
JPH084503B2 (ja) ウロキナーゼの回収方法及びそれにより得られるウロキナーゼ含有画分

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees